• Home
  • News
  • Fortune 500
    • Fortune Global 500
    • Fortune 500 Europe
    • Fortune China 500
    • Fortune SEA 500
    • Great Place to Work
  • Tech
    • AI
    • Innovation
    • Cybersecurity
  • Finance
    • Personal Finance
    • Real Estate
    • Economy
    • Investing
    • Banking
    • Crypto
  • Leadership
    • Success
    • Future of Work
    • Workplace Culture
    • C-Suite
    • CEO Initiative
  • Lifestyle
    • Arts & Entertainment
    • Travel & Leisure
    • Health
    • Well
    • Education
  • Rankings
    • Analytics
  • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Video
    • Podcasts
  • Home
  • News
  • FORTUNE 500
    • FORTUNE 500
    • FORTUNE SEA 500
    • Fortune 500 Europe
    • Fortune Global 500
    • Fortune China 500
    • Great Place to Work
  • Tech
    • Tech
    • AI
    • Innovation
    • Cybersecurity
  • Finance
    • Finance
    • Personal Finance
    • Real Estate
    • Economy
    • Banking
    • Investing
    • Crypto
  • Leadership
    • Leadership
    • Success
    • Future of Work
    • Workplace Culture
    • C-Suite
    • CEO Initiative
  • Lifestyle
    • Lifestyle
    • Arts & Entertainment
    • Travel & Leisure
    • Health
    • Well
    • Education
  • Rankings
    • Rankings
    • Analytics
  • Multimedia
    • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Video
    • Podcasts
  • Asia
  • Europe
  • Analytics
  1. home
  1. home
  2. Pharmaceutical Industry

Pharmaceutical Industry

Page 82 of 100

BRITAIN-PHARMACEUTICAL-GSK
Finance

Five Charged in U.S. With Stealing Secrets From GlaxoSmithKline

By Reuters
January 21, 2016
Senate Permanent Subcommittee On Investigations Hearing On U.S. Corporate Tax Code
Health

Valeant Vows to Make Its Drugs ‘Affordable’

By Laura Lorenzetti
January 13, 2016
Biosimilars Are Coming After Big Pharma’s Bottom Line
Health

Biosimilars Are Coming After Big Pharma’s Bottom Line

By Laura Lorenzetti
January 12, 2016
AbbVie Inc. To Buy Shire For $54.8 Billion
Health

Drugmaker Shire Is Buying Baxalta for $32 Billion

By Reuters
January 11, 2016
Pfizer In Merger Talks With Allergan PLC
Health

Pfizer Just Jacked Up Prices for All of These Drugs

By Reuters
January 9, 2016
AbbVie Inc. To Buy Shire For $54.8 Billion
Health

Shire’s Merger With Baxalta Merger Is Nearly Done

By Reuters
January 8, 2016
<> at Downsview Park on September 20, 2015 in Toronto, Canada.
Arts & Entertainment

Wu-Tang’s RZA Says He Doesn’t Care What Martin Shkreli Does with His Album

By Laura Lorenzetti
January 6, 2016
New York Mets v Washington Nationals
Arts & Entertainment

Why These Baseball Stars Are Suing Al Jazeera

By Michal Addady
January 6, 2016
Senate Permanent Subcommittee On Investigations Hearing On U.S. Corporate Tax Code
Health

Valeant Appoints Howard Schiller Interim CEO

By Reuters
January 6, 2016
AbbVie Inc. To Buy Shire For $54.8 Billion
International

Shire-Baxalta $32 Billion Merger Talks Said to Advance

By Michal Addady
January 3, 2016
US-CRIME-JUSTICE-SHKRELI
Health

Martin Shkreli’s Old Company Has Filed For Bankruptcy

By Reuters
December 30, 2015
sb10065848dh-001
Tech

New Research Shows How the Liver Fights off Sugar Cravings

By Hilary Brueck
December 29, 2015
J. Michael Pearson, chief executive officer, Valeant Pharmaceuticals International Inc., speaks during the Bloomberg Economic Series: Canada 2015 in Toronto, Ontario Thursday May 21/2015. (Photo by Kevin Van Paassen/Bloomberg)
Leadership

Valeant Will Be Run by a Group of Executives Until Its CEO Returns

By Reuters
December 28, 2015
J. Michael Pearson, chief executive officer, Valeant Pharmaceuticals International Inc., speaks during the Bloomberg Economic Series: Canada 2015 in Toronto, Ontario Thursday May 21/2015. (Photo by Kevin Van Paassen/Bloomberg)
Leadership

Valeant CEO J. Michael Pearson Hospitalized for ‘Severe’ Pneumonia

By Reuters
December 26, 2015
Martin Shkreli, CEO Reviled for Drug Price Gouging, Arrested on Securities Fraud Charges
Health

Aftershocks Keep Coming After Former Pharma CEO’s Arrest

By Reuters
December 24, 2015

Most Popular

  • AI
    Meta's 28-year-old billionaire prodigy says the next Bill Gates will be a 13-year-old who is 'vibe coding' right now
    By Eva Roytburg
  • Economy
    Trump's social security chief says 'everything' is on the table and retirement is about to get a 'different set of...
    By Eleanor Pringle
  • Economy
    Ray Dalio says the world is running out of interest in buying U.S. debt—but America is unable to cut back its spending
    By Eleanor Pringle
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • MPW
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms of Use
  • Single Issues for Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work at Fortune
  • Diversity and Inclusion
  • Terms and Conditions
  • Site Map

© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.